Jump to main content
Jump to site search

Issue 11, 2012
Previous Article Next Article

‘TamiGold’: phospha-oseltamivir-stabilised gold nanoparticles as the basis for influenza therapeutics and diagnostics targeting the neuraminidase (instead of the hemagglutinin)

Author affiliations

Abstract

The strong and selective binding of 2 types of gold nanoparticles that are decorated with the oseltamivir (aka TamifluTM) pharmacophore to wild-type and resistant influenza virus strains, including isolates from the 2009 pandemic, is reported. The particles interact with the virus neuraminidase rather than the hemagglutinin and could serve as a vantage point for novel influenza virus sensors, due to the intrinsic advantages of oseltamivir over the natural sialic acid ligand or even zanamivir.

Graphical abstract: ‘TamiGold’: phospha-oseltamivir-stabilised gold nanoparticles as the basis for influenza therapeutics and diagnostics targeting the neuraminidase (instead of the hemagglutinin)

Back to tab navigation

Supplementary files

Publication details

The article was received on 07 Feb 2012, accepted on 06 May 2012 and first published on 09 May 2012


Article type: Concise Article
DOI: 10.1039/C2MD20034A
Med. Chem. Commun., 2012,3, 1373-1376

  •   Request permissions

    ‘TamiGold’: phospha-oseltamivir-stabilised gold nanoparticles as the basis for influenza therapeutics and diagnostics targeting the neuraminidase (instead of the hemagglutinin)

    M. Stanley, N. Cattle, J. McCauley, S. R. Martin, A. Rashid, R. A. Field, B. Carbain and H. Streicher, Med. Chem. Commun., 2012, 3, 1373
    DOI: 10.1039/C2MD20034A

Search articles by author

Spotlight

Advertisements